STOCK TITAN

[DEFA14A] NanoVibronix, Inc. Additional Proxy Soliciting Materials

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
DEFA14A
Rhea-AI Filing Summary

NanoVibronix (NAOV) has filed a DEFA14A to correct an error in their previously filed proxy statement for the Special Meeting scheduled for July 11, 2025. The key correction relates to the outstanding preferred stock disclosure as of May 16, 2025 (Record Date).

The corrected share structure includes:

  • Common Stock: 2,282,746 shares
  • Series G Preferred Stock: 320,348 shares
  • Series X Preferred Stock: 57,720 shares

The company clarifies that no Series C, D, E, or F Preferred Stock are outstanding. Each common share carries one vote, with no cumulative voting rights. Stockholders who have already submitted their proxy votes do not need to take action unless they wish to change their vote. The stockholder list will be available for inspection at the company's headquarters for 10 days before the meeting.

NanoVibronix (NAOV) ha presentato un DEFA14A per correggere un errore nella loro precedente dichiarazione di delega relativa all'Assemblea Straordinaria prevista per il 11 luglio 2025. La correzione principale riguarda la divulgazione delle azioni privilegiate in circolazione alla data del 16 maggio 2025 (Data di Registrazione).

La struttura azionaria corretta include:

  • Azioni Ordinarie: 2.282.746 azioni
  • Azioni Privilegiate Serie G: 320.348 azioni
  • Azioni Privilegiate Serie X: 57.720 azioni

L'azienda precisa che non risultano in circolazione azioni privilegiate delle serie C, D, E o F. Ogni azione ordinaria conferisce un voto, senza diritti di voto cumulativi. Gli azionisti che hanno già espresso il proprio voto tramite delega non devono intraprendere alcuna azione, salvo desiderino modificare il proprio voto. L'elenco degli azionisti sarà disponibile per la consultazione presso la sede della società per 10 giorni prima dell'assemblea.

NanoVibronix (NAOV) ha presentado un DEFA14A para corregir un error en su declaración de poder previamente presentada para la Junta Especial programada para el 11 de julio de 2025. La corrección clave se refiere a la divulgación de las acciones preferentes en circulación al 16 de mayo de 2025 (Fecha de Registro).

La estructura accionaria corregida incluye:

  • Acciones Ordinarias: 2,282,746 acciones
  • Acciones Preferentes Serie G: 320,348 acciones
  • Acciones Preferentes Serie X: 57,720 acciones

La compañía aclara que no hay acciones preferentes de las Series C, D, E o F en circulación. Cada acción ordinaria otorga un voto, sin derechos de voto acumulativos. Los accionistas que ya hayan enviado sus votos por poder no necesitan hacer nada, a menos que deseen cambiar su voto. La lista de accionistas estará disponible para inspección en la sede de la empresa durante 10 días antes de la junta.

NanoVibronix (NAOV)는 2025년 7월 11일로 예정된 특별총회를 위한 이전에 제출한 위임장에 오류를 수정하기 위해 DEFA14A를 제출했습니다. 주요 수정 사항은 2025년 5월 16일(기준일) 기준 미결제 우선주 공시에 관한 내용입니다.

수정된 주식 구조는 다음과 같습니다:

  • 보통주: 2,282,746주
  • 시리즈 G 우선주: 320,348주
  • 시리즈 X 우선주: 57,720주

회사는 시리즈 C, D, E, F 우선주는 발행되지 않았음을 명확히 합니다. 보통주 한 주당 1표의 의결권이 있으며 누적 의결권은 없습니다. 이미 위임 투표를 제출한 주주는 투표 변경을 원하지 않는 한 별도의 조치를 취할 필요가 없습니다. 주주 명부는 총회 10일 전부터 회사 본사에서 열람할 수 있습니다.

NanoVibronix (NAOV) a déposé un DEFA14A afin de corriger une erreur dans leur déclaration de procuration précédemment soumise pour l'Assemblée Spéciale prévue le 11 juillet 2025. La correction principale concerne la divulgation des actions privilégiées en circulation au 16 mai 2025 (date d'enregistrement).

La structure des actions corrigée comprend :

  • Actions ordinaires : 2 282 746 actions
  • Actions privilégiées Série G : 320 348 actions
  • Actions privilégiées Série X : 57 720 actions

La société précise qu'aucune action privilégiée des séries C, D, E ou F n'est en circulation. Chaque action ordinaire donne droit à une voix, sans droit de vote cumulatif. Les actionnaires ayant déjà soumis leur procuration n'ont pas besoin d'agir, sauf s'ils souhaitent modifier leur vote. La liste des actionnaires sera disponible pour consultation au siège de la société pendant 10 jours avant l'assemblée.

NanoVibronix (NAOV) hat ein DEFA14A eingereicht, um einen Fehler in ihrer zuvor eingereichten Vollmachtsmitteilung für die außerordentliche Hauptversammlung am 11. Juli 2025 zu korrigieren. Die wesentliche Korrektur betrifft die Offenlegung der ausstehenden Vorzugsaktien zum 16. Mai 2025 (Stichtag).

Die korrigierte Aktienstruktur umfasst:

  • Stammaktien: 2.282.746 Stück
  • Vorzugaktien Serie G: 320.348 Stück
  • Vorzugaktien Serie X: 57.720 Stück

Das Unternehmen stellt klar, dass keine Vorzugsaktien der Serien C, D, E oder F ausstehen. Jede Stammaktie hat eine Stimme, ohne kumulative Stimmrechte. Aktionäre, die ihre Vollmacht bereits abgegeben haben, müssen nichts weiter unternehmen, es sei denn, sie möchten ihre Stimme ändern. Die Aktionärsliste wird 10 Tage vor der Versammlung am Firmensitz zur Einsicht bereitliegen.

Positive
  • None.
Negative
  • Company disclosed a material error in its previous proxy statement regarding outstanding preferred shares, revealing 320,348 Series G and 57,720 Series X Preferred shares were actually outstanding when initially reported as zero

NanoVibronix (NAOV) ha presentato un DEFA14A per correggere un errore nella loro precedente dichiarazione di delega relativa all'Assemblea Straordinaria prevista per il 11 luglio 2025. La correzione principale riguarda la divulgazione delle azioni privilegiate in circolazione alla data del 16 maggio 2025 (Data di Registrazione).

La struttura azionaria corretta include:

  • Azioni Ordinarie: 2.282.746 azioni
  • Azioni Privilegiate Serie G: 320.348 azioni
  • Azioni Privilegiate Serie X: 57.720 azioni

L'azienda precisa che non risultano in circolazione azioni privilegiate delle serie C, D, E o F. Ogni azione ordinaria conferisce un voto, senza diritti di voto cumulativi. Gli azionisti che hanno già espresso il proprio voto tramite delega non devono intraprendere alcuna azione, salvo desiderino modificare il proprio voto. L'elenco degli azionisti sarà disponibile per la consultazione presso la sede della società per 10 giorni prima dell'assemblea.

NanoVibronix (NAOV) ha presentado un DEFA14A para corregir un error en su declaración de poder previamente presentada para la Junta Especial programada para el 11 de julio de 2025. La corrección clave se refiere a la divulgación de las acciones preferentes en circulación al 16 de mayo de 2025 (Fecha de Registro).

La estructura accionaria corregida incluye:

  • Acciones Ordinarias: 2,282,746 acciones
  • Acciones Preferentes Serie G: 320,348 acciones
  • Acciones Preferentes Serie X: 57,720 acciones

La compañía aclara que no hay acciones preferentes de las Series C, D, E o F en circulación. Cada acción ordinaria otorga un voto, sin derechos de voto acumulativos. Los accionistas que ya hayan enviado sus votos por poder no necesitan hacer nada, a menos que deseen cambiar su voto. La lista de accionistas estará disponible para inspección en la sede de la empresa durante 10 días antes de la junta.

NanoVibronix (NAOV)는 2025년 7월 11일로 예정된 특별총회를 위한 이전에 제출한 위임장에 오류를 수정하기 위해 DEFA14A를 제출했습니다. 주요 수정 사항은 2025년 5월 16일(기준일) 기준 미결제 우선주 공시에 관한 내용입니다.

수정된 주식 구조는 다음과 같습니다:

  • 보통주: 2,282,746주
  • 시리즈 G 우선주: 320,348주
  • 시리즈 X 우선주: 57,720주

회사는 시리즈 C, D, E, F 우선주는 발행되지 않았음을 명확히 합니다. 보통주 한 주당 1표의 의결권이 있으며 누적 의결권은 없습니다. 이미 위임 투표를 제출한 주주는 투표 변경을 원하지 않는 한 별도의 조치를 취할 필요가 없습니다. 주주 명부는 총회 10일 전부터 회사 본사에서 열람할 수 있습니다.

NanoVibronix (NAOV) a déposé un DEFA14A afin de corriger une erreur dans leur déclaration de procuration précédemment soumise pour l'Assemblée Spéciale prévue le 11 juillet 2025. La correction principale concerne la divulgation des actions privilégiées en circulation au 16 mai 2025 (date d'enregistrement).

La structure des actions corrigée comprend :

  • Actions ordinaires : 2 282 746 actions
  • Actions privilégiées Série G : 320 348 actions
  • Actions privilégiées Série X : 57 720 actions

La société précise qu'aucune action privilégiée des séries C, D, E ou F n'est en circulation. Chaque action ordinaire donne droit à une voix, sans droit de vote cumulatif. Les actionnaires ayant déjà soumis leur procuration n'ont pas besoin d'agir, sauf s'ils souhaitent modifier leur vote. La liste des actionnaires sera disponible pour consultation au siège de la société pendant 10 jours avant l'assemblée.

NanoVibronix (NAOV) hat ein DEFA14A eingereicht, um einen Fehler in ihrer zuvor eingereichten Vollmachtsmitteilung für die außerordentliche Hauptversammlung am 11. Juli 2025 zu korrigieren. Die wesentliche Korrektur betrifft die Offenlegung der ausstehenden Vorzugsaktien zum 16. Mai 2025 (Stichtag).

Die korrigierte Aktienstruktur umfasst:

  • Stammaktien: 2.282.746 Stück
  • Vorzugaktien Serie G: 320.348 Stück
  • Vorzugaktien Serie X: 57.720 Stück

Das Unternehmen stellt klar, dass keine Vorzugsaktien der Serien C, D, E oder F ausstehen. Jede Stammaktie hat eine Stimme, ohne kumulative Stimmrechte. Aktionäre, die ihre Vollmacht bereits abgegeben haben, müssen nichts weiter unternehmen, es sei denn, sie möchten ihre Stimme ändern. Die Aktionärsliste wird 10 Tage vor der Versammlung am Firmensitz zur Einsicht bereitliegen.

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

SCHEDULE 14A INFORMATION

 

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No.    )

 

Filed by the Registrant
Filed by a Party other than the Registrant

 

Check the appropriate box:

 

Preliminary Proxy Statement
Confidential, for Use of the SEC Only (As Permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material Pursuant to § 240.14a-12

 

NanoVibronix, Inc.

(Name of Registrant as Specified in Its Charter)

 

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

 

No fee required.
Fee paid previously with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

 

 

 

 

 

SUPPLEMENT TO DEFINITIVE PROXY STATEMENT

FOR THE SPECIAL MEETING OF STOCKHOLDERS

TO BE HELD ON JULY 11, 2025

 

EXPLANATORY NOTE

 

On June 20, 2025, NanoVibronix, Inc. (the “Company”) filed with the Securities and Exchange Commission (the “SEC”) a definitive proxy statement on Schedule 14A (the “Proxy Statement”) relating to the Company’s Special Meeting of Stockholders (the “Special Meeting”) to be held on Friday, July 11, 2025, commencing at 10:00 a.m., Eastern Time. As previously disclosed, the board of directors of the Company has fixed the close of business on May 16, 2025, as the record date (the “Record Date”) for determining stockholders entitled to vote at the Special Meeting and at any adjournment(s) or postponement(s) thereof. Capitalized terms used in this supplement to the Proxy Statement (this “Supplement”) without definition have the same meanings as set forth in the Proxy Statement.

 

This Supplement is being filed to correct an inadvertent error in the number of shares of preferred stock reported as outstanding as of the Record Date on page 3 of the Proxy Statement. On page 3 thereof, the Proxy Statement previously stated that there were no shares of any series of preferred stock outstanding, when there were 320,348 shares of Series G Preferred Stock and 57,720 shares of Series X Preferred Stock of the Company issued and outstanding as of the Record Date. This change solely affects the disclosure as related to such shares of preferred stock outstanding as of the Record Date as reported on page 3 of the Proxy Statement.

  

This Supplement should be read in conjunction with the Proxy Statement. Except as specifically amended or supplemented by the information contained herein, this Supplement does not otherwise modify, amend or supplement the Proxy Statement, and the information contained in the Proxy Statement should be considered in voting your shares. From and after the date of this Supplement, any references to the “Proxy Statement” are to the Proxy Statement as supplemented hereby.

 

If you have already returned your proxy card or provided voting instructions, you do not need to take any action unless you wish to change your vote.

 

***

 

The following text replaces, in its entirety, the text on page 3 of the Proxy Statement appearing below “Who is entitled to vote at the Special Meeting and how many votes do they have?”

 

Holders of Common Stock at the close of business on the Record Date, may vote at the Special Meeting. There were 2,282,746 shares of Common Stock, 0 shares of Series C Preferred Stock, 0 shares of Series D Preferred Stock, 0 shares of Series E Preferred Stock, 0 shares of Series F Preferred Stock, 320,348 shares of Series G Preferred Stock and 57,720 shares of Series X Preferred Stock issued and outstanding on the Record Date. A complete list of registered stockholders entitled to vote at the Special Meeting will be available for inspection at the principal executive offices of the Company during regular business hours for the 10 calendar days prior to the Special Meeting.

 

Pursuant to the rights of our stockholders contained in our charter documents, each share of our Common Stock is entitled to one vote on all matters listed in this proxy statement. There is no cumulative voting. 

 

 

 

FAQ

When is NAOV's Special Meeting of Stockholders scheduled for 2025?

NAOV's Special Meeting of Stockholders is scheduled for Friday, July 11, 2025, at 10:00 a.m. Eastern Time.

How many shares of NAOV preferred stock were outstanding as of May 16, 2025?

As of the Record Date (May 16, 2025), NAOV had 320,348 shares of Series G Preferred Stock and 57,720 shares of Series X Preferred Stock outstanding. No shares of Series C, D, E, or F Preferred Stock were outstanding.

What was the purpose of NAOV's DEFA14A filing on June 28, 2025?

The DEFA14A was filed to correct an error in the original proxy statement regarding the number of preferred shares outstanding. The initial statement incorrectly reported no preferred shares outstanding, when in fact there were Series G and Series X preferred shares issued.

How many shares of NAOV common stock were outstanding as of the record date?

As of the Record Date (May 16, 2025), NAOV had 2,282,746 shares of Common Stock issued and outstanding.

Do NAOV shareholders need to take action if they already submitted their proxy vote?

No, shareholders who have already returned their proxy card or provided voting instructions do not need to take any action unless they wish to change their vote.
Nanovibronix Inc

NASDAQ:NAOV

NAOV Rankings

NAOV Latest News

NAOV Latest SEC Filings

NAOV Stock Data

2.38M
735.53k
0.95%
2%
3.07%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
TYLER